REFERENCES
1.Pallan S, Rahman MO, Khan AA. Diagnosis and management of primary
hyperparathyroidism. BMJ. 2012; 344: e1013.
2. M.D. Walker and S.J. Silverberg Cardiovascular aspects of primary
hyperparathyroidism J Endocrinol Invest. 2008 October; 31(10): 925–931.
3. January CT, Wann LS, Alpert JS, et al: 2014 AHA/ACC/HRS guideline for
the management of patients with atrial fibrillation: A report of the
american college of cardiology/american heart association task force on
practice guidelines and the heart rhythm society. Journal of
the American College of Cardiology. 2014;64: e1-76.
4. Komatsu T, Kunugita F, Ozawa M, et al: Relationship between
Impairment of the Vascular Endothelial Function and the CHA2DS2-VASc
Score in Patients with Sinus Rhythm and Non-valvular Atrial
Fibrillation. Intern Med. 2018;57(15):2131-2139.
5. Deniz A, Sahiner L, Aytemir K, et al: Tissue Doppler echocardiography
can be a useful technique to evaluate atrial conduction time. Cardiol J
2012; 19:487–493.
6. Daubert JC, Pavin D, Jauvert G, et al: Intra and interatrial
conduction delay: implications for cardiac pacing. Pacing Clin
Electrophysiol 2004; 27:507
7. Perk J, De Backer G, Gohlke H, et al: European Guidelines on
cardiovascular disease prevention in clinical practice (version 2012).
The Fifth Joint Task Force of the European Society of Cardiology and
Other Societies on Cardiovascular Disease Prevention in Clinical
Practice (constituted by representatives of nine societies and by
invited experts). Eur Heart J 2012; 33:1635–701
8. Cheitlin MD, Armstrong WF, Aurigemma GP, et al: ACC/AHA/ASE 2003
guideline up- date for the clinical application of echocardiography:
summary article: a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE
Committee to Update the 1997 Guidelines for the Clinical Application of
Echocardiography). Circulation 2003; 108: 1146–1162.
9. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism
and heart disease: a review. Eur Heart J 2004; 25:1776 – 87
10. Kosch M, Hausberg M, Vormbrock K, et al: Studies on flow- mediated
vasodilation and intima-media thickness of the brachial artery in
patients with primary hyperparathyroidism. Am J Hypertens. 2000;
13:759–64
11. Gennari C, Nami R, Gonnelli S. Hypertension and primary
hyperparathyroidism: the role of adrenergic and
renin-angiotensin-aldosterone systems. Miner Electrolyte Metab. 1995;
21:77–81.
12. Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory
function and blood pressure response to local and systemic
hypercalcemia. Surgery. 2001; 130:986–90.
13. Kepez A, Yasar M, Sunbul M, et al: Evaluation of left ventricular
functions in patients with primary hyperparathyroidism: is there any
effect of parathyroidectomy? Wien Klin Wochenschr. 2017
May;129(9-10):329-336.
14. Ozdemir D, Kalkan GY, Bayram NA, et al: Evaluation of left ventricle
functions by tissue Doppler, strain, and strain rate echocardiography in
patients with primary hyperparathyroidism. Endocrine. 47: 609-17 (2014).
15. Ekmekci A, Abaci N, Colak Ozbey N, et al: Endothelial function and
endothelial nitric oxide synthase intron 4a/b polymorphism in primary
hyperparathyroidism. J. Endocrinol. Invest. 32: 611-16 (2009).
16. Lind L, Ljunghall S. Serum calcium and the ECG in patients with
primary hyperparathyroidism. Journal of Electrocardiology. 27: 99–103
(1994).
17. Surawicz B. Role of electrolytes in etiology and management of
cardiac arrhythmias. Prog Cardiovasc Dis. 8:364–86 (1966).
18. Cui QQ, Zhang W, Wang H, et al: Assessment of atrial
electromechanical coupling and influential factors in nonrheumatic
paroxysmal atrial fibrillation. Clin Cardiol 2008; 31:74.
19. Roshanali F, Mandegar MH, Yousefnia MA, et al: Prevention of atrial
fibrillation after coronary artery bypass grafting via atrial
electromechanical interval and use of amiodarone prophylaxis. Interact
Cardiovasc Thorac Surg 2009; 8:421–425.
20. Bakirci EM, Demirtas L, Degirmenci H, et al: Relationship of the
total atrial conduction time to subclinical atherosclerosis,
inflammation and echocardiographic parameters in patients with type 2
diabetes mellitus. Clinics (Sao Paulo). 2015;70(2):73-80.
21. Ermiş N, Açıkgöz N, Yaşar E, et al: Evaluation of atrial conduction
time by P-wave dispersion and tissue Doppler echocardiography in
prehypertensive patients. Turk Kardiyol Dern Ars 2010; 38:525–530.
22. Ozer N, Yavuz B, Can I, et al: Doppler tissue evaluation of
intra-atrial and interatrial elec- tromechanical delay and comparison
with P- wave dispersion in patients with mitral stenosis. J Am Soc
Echocardiogr 2005;18: 945–948.
23. Calapkorur B, Kelesoglu B, Sarli B, et al: Atrial Electromechanical
Delay Is Impaired in Patients with Psoriasis. Med Princ Pract
2015;24:30–35.
24. Efe TH, Cimen T, Ertem AG et al: Atrial Electromechanical Properties
in Inflammatory Bowel Disease. Echocardiography 2016 Sep;33(9):1309-16
25. Deniz A, Yavuz B, Aytemir K, et al: Intra- left atrial mechanical
delay detected by tissue Doppler echocardiography can be a useful marker
for paroxysmal atrial fibrillation. Echocardiography 2009; 26:779–784.
26. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez Font E,
Aris A, Cinca J. Atrial fibrillation is associated with increased
spontaneous calcium release from the sarcoplasmic reticulum in human
atrial myocytes. Circulation. 2004; 110:1358 –1363
27. Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q,
Wieland T, Ravens U, Nattel S et al. Enhanced sarcoplasmic reticulum
Ca2+ leak and increased Na+- Ca2+ exchanger function underlie delayed
after depolarizations in patients with chronic atrial fibrillation.
Circulation 2012 125 2059–2070. (doi: 10.1161/ CIRCULATION
AHA.111.067306)
28. Rosenqvist M, Nordenström J, Andersson M, Edhag OK. Cardiac
conduction in patients with hypercalcaemia due to primary
hyperparathyroidism. Clin Endocrinol (Oxf). 1992; 37:29–33.
29. Dalberg K, Brodin LA, Juhlin-Dannfelt A, Famebo LO. Cardiac function
in primary hyperparathyroidism before and after operation. An
echocardiographic study. Eur J Surg. 1996; 162:171–6.
30. Curione M, Letizia C, Amato S et all. Increased risk of cardiac
death in primary hyperparathyroidism: what is a role of electrical
instability? Int J Cardiol. 2007 Oct 1;121(2):200-2
31. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the
cardiac effects of parathyroid hormone (PTH) and PTH-related protein.
Endocrinology. 1995; 136:3024–30.
32. Cheng S-P, Liu C-L, Liu T-P, Hsu Y-C, Lee J-J. Association between
parathyroid hormone levels and inflammatory markers among US adults.
Mediat Inflamm 2014;2014:1-8.
33. Shor R, Tilis Y, Boaz M, Matas Z, Fux A et al. Serum parathyroid
hormone-related protein levels before and after paroxysmal atrial
fibrillation. American Journal Emergency Medicine 2008; 26:361-363. doi:
10.1016/j.ajem.2007.08.005.
34. Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH et al.
Elevated parathyroid hormone, but not vitamin D deficiency, is
associated with increased risk of heart failure in older men with and
without cardiovascular disease. Circulation Heart Failure 2014;
7:732-739. doi: 10.1161/CIRC HEART FAILURE.114.001272
35. Rienstra M, Lubitz SA, Zhang ML, Cooper RR, Ellinor PT. Elevation of
parathyroid hormone levels in atrial fibrillation. J Am Coll Cardiol.
2011;57(25):2542-2543. doi:10.1016/j.jacc.2011.01.041
36. Lee KH, Shin MH, Park HW, Cho JG, Kweon SS et al. Association
between Serum Parathyroid Hormone Levels and the Prevalence of Atrial
Fibrillation: the Dong-gu Study. Korean Circulation Journal.
2018;48(2):159-167. doi: 10.4070/kcj.2017.0187.
37. Pepe J, Cipriani C, Curione M, Biamonte F, Colangelo L, Danese V,
Cecchetti V, Sonato C, Ferrone F, Cilli M, Minisola S. Reduction of
arrhythmias in primary hyperparathyroidism, by parathyroidectomy,
evaluated with 24-h ECG monitoring. Eur. J. Endocrinol. 179(2):117-124
(2018)